Construction and immunogenicity evaluation of chimerical DNA vaccine of human papillomavirus type 11 / 中华实验和临床病毒学杂志
Chinese Journal of Experimental and Clinical Virology
; (6): 182-184, 2009.
Article
in Zh
| WPRIM
| ID: wpr-325597
Responsible library:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To construct chimerical DNA vaccine plasmid of human papillomavirus type 11 (HPV11) L1-E7, and to evaluate its immunogenicity.</p><p><b>METHODS</b>Molecular cloning techniques were used to construct recombinant plasmid pcDNA3 L1-E7 as a DNA vaccine. BALB/c mice were vaccinated with DNA recombinants through muscle injection.IL-2 and gamma-INF secreted by immunized spleens lymphocyte and HPV 11 L1 or E7 specific antibodies were assayed by ELISA method. Spleens lymphocyte proliferation was measured by MTT assay.</p><p><b>RESULTS</b>The chimerical DNA plasmid of pcDNA3 L1-E7 was constructed correctly. Specific anti-HPV11 E7 and L1 antibodies, specific lymphocyte proliferation and secretions of IL-2 and gamma-INF were detected in vaccinated mice.</p><p><b>CONCLUSION</b>Specific immune response, including cellular immunity and humoral immunity, could been detected in mice vaccinated with chimerical DNA vaccine of pcDNA3 L1-E7.</p>
Full text:
1
Database:
WPRIM
Main subject:
Virology
/
Blood
/
Molecular Sequence Data
/
Base Sequence
/
Random Allocation
/
Genetic Engineering
/
Vaccines, DNA
/
Papillomavirus Infections
/
Allergy and Immunology
/
Human papillomavirus 11
Type of study:
Clinical_trials
Limits:
Animals
/
Female
/
Humans
Language:
Zh
Journal:
Chinese Journal of Experimental and Clinical Virology
Year:
2009
Document type:
Article